No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Jefferies Maintains Revolution Medicines(RVMD.US) With Buy Rating, Raises Target Price to $86
One Revolution Medicines Insider Raised Their Stake In The Previous Year
S&P 500 Futures Up In Premarket Trading; Oracle, Ferguson Enterprises Lag
Revolution Medicines Director Schroeder Acquires $59.9m in Stock
Needham Maintains Revolution Medicines(RVMD.US) With Buy Rating, Cuts Target Price to $62
Wedbush Maintains Revolution Medicines(RVMD.US) With Buy Rating, Cuts Target Price to $67
No Data